SciELO - Scientific Electronic Library Online

 
vol.21 número6Modelado de Procesos de Negocio para la Gestión de Patentes en UniversidadesUn Modelo para la Homogeneización de las Clases Textuales de la Biblioteca Electrónica Scielo-Chile: la Variabilidad del Artículo de Investigación en Diversas Disciplinas índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Información tecnológica

versão On-line ISSN 0718-0764

Resumo

CALVO, Begoña  e  ZUNIGA, Leyre. Biological Medicinal Products: Requirements for the Development and Approval of Biosimilars. Inf. tecnol. [online]. 2010, vol.21, n.6, pp.125-132. ISSN 0718-0764.  http://dx.doi.org/10.4067/S0718-07642010000600014.

This article reviews the European guidelines on drugs comparability that establish the methodology for verifying biosimilarity between the so-called biosimilar drugs and the reference biological medicinal product. Biosimilars are biological medicines similar but not identical to the original drugs and can be manufactured by any laboratory after the expiration of biotech drugs patent. The guidelines of the European Medicines Agency (EMA) and the International Conference on Harmonization (ICH) that must be considered in the development and approval of these drugs also are reviewed. It is shown that biosimilars cannot be considered as generic drugs, being necessary to conduct additional assays prior to obtain marketing authorization.

Palavras-chave : biosimilars; biotech drugs; drugs regulation; eneric drugs.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons